Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Human endogenous retrovirus K(HML-2) Gag- and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening.

Jones RB, John VM, Hunter DV, Martin E, Mujib S, Mihajlovic V, Burgers PC, Luider TM, Gyenes G, Sheppard NC, Sengupta D, Tandon R, Yue FY, Benko E, Kovacs C, Nixon DF, Ostrowski MA.

Clin Vaccine Immunol. 2012 Feb;19(2):288-92. doi: 10.1128/CVI.05583-11. Epub 2011 Dec 28.

2.

Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.

Jones RB, Leal FE, Hasenkrug AM, Segurado AC, Nixon DF, Ostrowski MA, Kallas EG.

J Negat Results Biomed. 2013 Jan 10;12:3. doi: 10.1186/1477-5751-12-3.

3.

HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.

Jones RB, Garrison KE, Mujib S, Mihajlovic V, Aidarus N, Hunter DV, Martin E, John VM, Zhan W, Faruk NF, Gyenes G, Sheppard NC, Priumboom-Brees IM, Goodwin DA, Chen L, Rieger M, Muscat-King S, Loudon PT, Stanley C, Holditch SJ, Wong JC, Clayton K, Duan E, Song H, Xu Y, SenGupta D, Tandon R, Sacha JB, Brockman MA, Benko E, Kovacs C, Nixon DF, Ostrowski MA.

J Clin Invest. 2012 Dec;122(12):4473-89. doi: 10.1172/JCI64560. Epub 2012 Nov 12.

4.

Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.

Contreras-Galindo R, Kaplan MH, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Ferlenghi I, Giusti F, Lorenzo E, Gitlin SD, Dosik MH, Yamamura Y, Markovitz DM.

J Virol. 2012 Jan;86(1):262-76. doi: 10.1128/JVI.00602-11. Epub 2011 Oct 26.

5.

Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection.

SenGupta D, Tandon R, Vieira RG, Ndhlovu LC, Lown-Hecht R, Ormsby CE, Loh L, Jones RB, Garrison KE, Martin JN, York VA, Spotts G, Reyes-Terán G, Ostrowski MA, Hecht FM, Deeks SG, Nixon DF.

J Virol. 2011 Jul;85(14):6977-85. doi: 10.1128/JVI.00179-11. Epub 2011 Apr 27.

6.

Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.

Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y.

AIDS Res Hum Retroviruses. 2006 Oct;22(10):979-84.

7.

HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors.

Kleiman A, Senyuta N, Tryakin A, Sauter M, Karseladze A, Tjulandin S, Gurtsevitch V, Mueller-Lantzsch N.

Int J Cancer. 2004 Jun 20;110(3):459-61.

8.

Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.

Gonzalez-Hernandez MJ, Swanson MD, Contreras-Galindo R, Cookinham S, King SR, Noel RJ Jr, Kaplan MH, Markovitz DM.

J Virol. 2012 Aug;86(15):7790-805. doi: 10.1128/JVI.07215-11. Epub 2012 May 16.

9.

HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production.

Bhardwaj N, Maldarelli F, Mellors J, Coffin JM.

J Virol. 2014 Oct;88(19):11108-20. doi: 10.1128/JVI.01623-14. Epub 2014 Jul 23.

10.

HIV-1 Infection of Primary CD4+ T Cells Regulates the Expression of Specific Human Endogenous Retrovirus HERV-K (HML-2) Elements.

Young GR, Terry SN, Manganaro L, Cuesta-Dominguez A, Deikus G, Bernal-Rubio D, Campisi L, Fernandez-Sesma A, Sebra R, Simon V, Mulder LCF.

J Virol. 2017 Dec 14;92(1). pii: e01507-17. doi: 10.1128/JVI.01507-17. Print 2018 Jan 1.

PMID:
29046457
11.

Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein.

Gonzalez-Hernandez MJ, Cavalcoli JD, Sartor MA, Contreras-Galindo R, Meng F, Dai M, Dube D, Saha AK, Gitlin SD, Omenn GS, Kaplan MH, Markovitz DM.

J Virol. 2014 Aug;88(16):8924-35. doi: 10.1128/JVI.00556-14. Epub 2014 May 28.

12.

Development of an antigen-capture ELISA for the detection of the p27-CA protein of HERV-K(HML-2).

Hohn O, Mostafa S, Norley S, Bannert N.

J Virol Methods. 2016 Aug;234:186-92. doi: 10.1016/j.jviromet.2016.04.016. Epub 2016 Apr 30.

PMID:
27142113
13.

A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis.

Freimanis G, Hooley P, Ejtehadi HD, Ali HA, Veitch A, Rylance PB, Alawi A, Axford J, Nevill A, Murray PG, Nelson PN.

Clin Exp Immunol. 2010 Jun;160(3):340-7. doi: 10.1111/j.1365-2249.2010.04110.x. Epub 2010 Mar 16.

14.

Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects.

Tandon R, SenGupta D, Ndhlovu LC, Vieira RG, Jones RB, York VA, Vieira VA, Sharp ER, Wiznia AA, Ostrowski MA, Rosenberg MG, Nixon DF.

J Virol. 2011 Nov;85(21):11526-31. doi: 10.1128/JVI.05418-11. Epub 2011 Aug 31.

15.

Human endogenous retrovirus expression is inversely associated with chronic immune activation in HIV-1 infection.

Ormsby CE, Sengupta D, Tandon R, Deeks SG, Martin JN, Jones RB, Ostrowski MA, Garrison KE, Vázquez-Pérez JA, Reyes-Terán G, Nixon DF.

PLoS One. 2012;7(8):e41021. doi: 10.1371/journal.pone.0041021. Epub 2012 Aug 7.

16.

Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma.

Rakoff-Nahoum S, Kuebler PJ, Heymann JJ, E Sheehy M, Ortiz GM, S Ogg G, Barbour JD, Lenz J, Steinfeld AD, Nixon DF.

AIDS Res Hum Retroviruses. 2006 Jan;22(1):52-6.

PMID:
16438646
17.

Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers.

de Mulder M, SenGupta D, Deeks SG, Martin JN, Pilcher CD, Hecht FM, Sacha JB, Nixon DF, Michaud HA.

Retrovirology. 2017 Aug 22;14(1):41. doi: 10.1186/s12977-017-0365-2.

18.

Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells.

Fuchs NV, Loewer S, Daley GQ, Izsvák Z, Löwer J, Löwer R.

Retrovirology. 2013 Oct 24;10:115. doi: 10.1186/1742-4690-10-115.

19.

Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21.

Ruprecht K, Ferreira H, Flockerzi A, Wahl S, Sauter M, Mayer J, Mueller-Lantzsch N.

J Virol. 2008 Oct;82(20):10008-16. doi: 10.1128/JVI.01016-08. Epub 2008 Aug 6.

20.

Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element.

George M, Schwecke T, Beimforde N, Hohn O, Chudak C, Zimmermann A, Kurth R, Naumann D, Bannert N.

Retrovirology. 2011 May 9;8:30. doi: 10.1186/1742-4690-8-30.

Supplemental Content

Support Center